Randomized trial shows improved diabetes outcomes through CGM initiation and support services, highlighting effective care strategies.
Introduction and Objective: Despite advances in diabetes management, people in southeastern Ohio face barriers to achieving glycemic goals. Reasons include limited access to diabetes education, low uptake of continuous glucose monitoring (CGM), and less access to primary care and specialists. We aimed to increase the percentage of people with type 2 diabetes who received diabetes navigation services, CGM initiation, and pharmacist interventions. Methods: We used the Institute for Healthcare Improvement’s Model for Improvement PDSA cycles. Control charts using EHR data tracked CGM prescriptions, scheduled follow-up within 30 days, and the percentage of A1C >= 9% in an adult population with diabetes. Results: During the two-year project, CGM prescribing increased from a mean of 1.9% to 33.4% and the percentage of people at the time of the visit with A1C >=9 decreased from a mean of 16.1% to 11.7%. Conclusion: Increasing CGM prescribing, navigation, and pharmacist support strengthened diabetes care capacity and contributed to improved A1C outcomes. Disclosure A. Fitzgerald: None. C. Fisher: None. R. Lahrman: None. D. Hartman: None. L.J. Lammert: None. H. Goodell: None. S. Miller-Branam: None. S.E. Adkins: None. A. Healy: Consultant; Ended; Novo Nordisk. Speaker's Bureau; Current; Sanofi. E.A. Beverly: None. Funding Ohio Department of Medicaid Grant G-2627-05-0009/ODM202619
No takes yet. Share an insight, caveat, or question.
FITZGERALD et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: